Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases.

Stephen Shuttleworth, Franck Silva, Cyrille Tomassi, Alexander Cecil, Thomas Hill, Helen Rogers, Paul Townsend

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	81-131
Number of pages	50
Journal	Progress in medicinal chemistry
Volume	48
DOIs	https://doi.org/10.1016/S0079-6468(09)04803-6
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{91e22a3a72da434b8817c5c5d2d7edb5,

title = "Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases.",

author = "Stephen Shuttleworth and Franck Silva and Cyrille Tomassi and Alexander Cecil and Thomas Hill and Helen Rogers and Paul Townsend",

year = "2009",

doi = "10.1016/S0079-6468(09)04803-6",

language = "English",

volume = "48",

pages = "81--131",

journal = "Progress in medicinal chemistry",

issn = "0079-6468",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases.

AU - Shuttleworth, Stephen

AU - Silva, Franck

AU - Tomassi, Cyrille

AU - Cecil, Alexander

AU - Hill, Thomas

AU - Rogers, Helen

AU - Townsend, Paul

PY - 2009

Y1 - 2009

U2 - 10.1016/S0079-6468(09)04803-6

DO - 10.1016/S0079-6468(09)04803-6

M3 - Article

C2 - 21544958

SN - 0079-6468

VL - 48

SP - 81

EP - 131

JO - Progress in medicinal chemistry

JF - Progress in medicinal chemistry

ER -